Description
Bevacizumab injection is a monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), effectively blocking tumor angiogenesis. It is used to treat various cancers, including colorectal, lung, kidney, and glioblastoma, often in combination with chemotherapy to enhance treatment response and progression-free survival.